Strong evidence.

The CPT® cold plasma adjunctive therapy solution has been proven effective.

What is the current state of research and evidence regarding cold plasma?

Scientifically researched and professionally evaluated

Extensive research demonstrates the effectiveness of cold plasma.
Leading professional associations also confirm its clinical relevance.

In its latestposition paper , the European Wound Management Association (EWMA) has systematically reviewedinternational studies, clinical data, and other scientific evidence regarding the use of cold plasma.

Cold plasma can
reduce the bacterial load on the
wound—including
multidrug-resistant
pathogens—reliably

Cold plasma can
stimulate
cell regeneration
and tissue repair
.2

Cold plasma can
limit infections and prevent further
spread.²

Cold plasma is
used
perceived
and
and is generally
well tolerated.²

Cold plasma can therefore help heal wounds that are difficult to heal.²

Current evidence on large-area CPT® cold plasma therapy

Power Study

The largest ongoing study to date on large-area CPT® cold plasma (POWER) is being conducted in collaboration with the German Society for Wound Healing and is the first IQWiG-compliant (here is the link; please link only the word: https://www.iq-
wig.de/) study on cold plasma that meets these requirements.

The interim results show that CPT® cold plasma therapy is significantly more effective than standard wound therapy (SWT) for chronic lower-leg wounds:

Accelerated wound healing
Study: 215% Faster Wound Healing Rate
Pain relief
Study on Antibiotic Needs
Improving quality of life
Study on Pain Relief
Reduced need for antibiotics
ruth-wollgast

Accelerated wound healing


Compared to the SWT group, the wound closure factor in the CPT group increased significantly to 214%.
This indicates that wounds heal significantly faster with CPT® treatment.³

Pain relief

Patients in the CPT group reported less wound pain, and a reduction in passive pain to 0 (median) was recorded.³

Improving quality of life

In patients in the CPT group, a marked and clinically significant improvement in quality of life was observed.
³

Reduced need for antibiotics

The CPT group required antibiotics in only 4% of cases, compared with 23% in the SWT group.³

Other publications

Additional clinical publications on large-area CPT® cold plasma:

#chronic wounds #vasculitis #lymphedema #post-thrombotic syndrome #diabetes mellitus
  •  

    "Cold plasma therapy for
    various types of wounds:
    Results of a pilot study."

    Abu Rached et al. (2025),
    Current Dermatology

#Multi-drug-resistant colonized burns #Large-area cold plasma therapy #dermal skin substitute #skin transplantation #skin substitutes
  • "The Successful Treatment
    of Multi-Resistant Colonized
    Burns with Large-Area Cold
    Plasma Therapy and Dermis
    Substitute Matrix–A Case Report."

    Milewski et al. (2024), *
    * *European Burn Journal*

#Chronic non-healing wound #Complete healing in 8 weeks #Non-invasive therapy #No adverse effects
  •  

    "Use of Cold Plasma in
    Wound Healing: A Case Report."

    Landscheidt et al. (2022), “
    ” Advances in Skin & Wound Care

Upcoming Publications

We are constantly working to generate new evidence:

POWER Study: Final results are expected in the second half of 2026

Antimicrobial study: Cold Atmospheric Plasma Reduces Wound Bioburden: The final results are expected shortly.

Be the first to know the results—sign up so you don’t miss out on the latest clinical evidence.

Users of the CPT® product platform particularly appreciate:

Quick application

Just 2 minutes per treatment

Standardized and reproducible

No manual device guidance

No additional gas required

CPT® Cold Plasma uses ambient air

Suitable for large-scale use

(including for wound areas larger than 100 cm² or entire body parts)

Versatile

Can be used with a sterile pouch for hard-to-reach wounds

Easy to integrate into existing workflows

e.g., can also be used during surgery

Versatile and easy to mix and match

e.g., using negative pressure therapy, skin substitutes, or tissue grafts

Evidence-based and clinically validated

e.g., the POWER study

Integration with existing workflows
device-slide
About the workflow
workflow slide
Safety and Regulatory Approval
competence slide

Integration with existing workflows

About the workflow

Safety and Regulatory Approval

Questions or concerns?

Contact us

For your inquiries or further information, please feel free to use the adjacent contact form.

Call us

+49 3834 7714700

You can find information on data protection here.
You can find information on data protection here.
You can find information on data protection here.